Jakubo | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

17 results for “Jakubo”

Trials

View all 12 →

CJD (Creutzfeldt-Jakob Disease) Quinacrine Study

69 participants · First posted Sep 16, 2005

Efavirenz for the Treatment of Creutzfeldt-Jakob Disease

246 participants · First posted Mar 19, 2026

Evaluation of Diagnostic Criteria for Creutzfeldt Jakob Disease

30 participants · First posted Jun 30, 2021

Organizations

JAKUB ANTCZAK

Poland

News

Onconic Therapeutics Advances Global Expansion of GERD Drug Jakubo with Mexico NDA Filing and U.S. Manufacturing Partnership

Onconic Therapeutics Secures U.S. Patent for Nesuparib Crystalline Form and Manufacturing Method

Onconic's Jaqbo Shows 100% Efficacy in Phase 3 Gastric Ulcer Trial, Seeks Indication Expansion

Page 1 of 2